BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6351310)

  • 1. Treatment of lymphoid tumors with anti-idiotype antibodies.
    Stevenson GT; Stevenson FK
    Springer Semin Immunopathol; 1983; 6(1):99-115. PubMed ID: 6351310
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-idiotype antibodies reveal the existence of somatic mutation in human B cell lymphoma.
    Levy R; Levy S; Brown SL; Kon S; Carroll W
    Monogr Allergy; 1987; 22():194-203. PubMed ID: 3325832
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
    Foon KA
    N Engl J Med; 1982 Sep; 307(11):686-7. PubMed ID: 6981064
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses.
    Lowder JN; Meeker TC; Campbell M; Garcia CF; Gralow J; Miller RA; Warnke R; Levy R
    Blood; 1987 Jan; 69(1):199-210. PubMed ID: 2431729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologicals for cancer treatment: monoclonal antibodies.
    Levy R
    Hosp Pract (Off Ed); 1985 Nov; 20(11):67-74, 77, 80-4 passim. PubMed ID: 3932392
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serotherapy of leukemia and lymphoma using monoclonal antibodies].
    Rupniewska ZM
    Pol Tyg Lek; 1985 Aug; 40(33):942-7. PubMed ID: 2997760
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatic mutation in human B-cell tumors.
    Levy R; Levy S; Cleary ML; Carroll W; Kon S; Bird J; Sklar J
    Immunol Rev; 1987 Apr; 96():43-58. PubMed ID: 3298008
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro tests that predict tumor-associated idiotype levels in the serum of patients with B cell lymphomas and leukemias.
    Miller RA; Lowder JN; Gralow J; Meeker T; Levy R
    Blood; 1987 Apr; 69(4):1249-54. PubMed ID: 3103720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivatives of anti-idiotype antibodies in the treatment of B-cell lymphoma.
    Glennie MJ; Stevenson GT
    Adv Exp Med Biol; 1985; 186():843-53. PubMed ID: 3876727
    [No Abstract]   [Full Text] [Related]  

  • 10. Involvement of innate and induced anti-idiotypic mechanisms in suppression of B cell tumors.
    Stevenson FK; George AJ; Tutt AL; Glennie MJ; Stevenson GT
    Monogr Allergy; 1987; 22():184-93. PubMed ID: 3501833
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigen-induced murine B-cell lymphomas. III. Passive anti-idiotype serum therapy and its combined effect with chemotherapy.
    Lanier LL; Babcock GF; Lynes MA; Haughton G
    J Natl Cancer Inst; 1979 Dec; 63(6):1417-22. PubMed ID: 316036
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.
    Meeker T; Lowder J; Cleary ML; Stewart S; Warnke R; Sklar J; Levy R
    N Engl J Med; 1985 Jun; 312(26):1658-65. PubMed ID: 3923352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of alternative methodologies for the generation of murine monoclonal anti-idiotypic antibodies to human B cell leukemias and lymphomas.
    Giardina SL; Foon KA; Beatty SM; Morgan AC
    J Immunol Methods; 1986 May; 89(1):1-7. PubMed ID: 3517169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotypic--anti-idiotypic interactions in man.
    Geha RS
    Am J Dis Child; 1985 Apr; 139(4):417-20. PubMed ID: 2579545
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes.
    Levy R; Meeker T; Lowder J; Levy S; Thielemans K; Warnke RA; Cleary ML; Sklar J
    Symp Fundam Cancer Res; 1986; 38():261-8. PubMed ID: 3529276
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
    George AJ; Tutt AL; Stevenson FK
    J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.
    Scheinberg DA
    Curr Opin Immunol; 1991 Oct; 3(5):679-84. PubMed ID: 1661602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
    Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
    J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells.
    Kiyotaki M; Cooper MD; Bertoli LF; Kearney JF; Kubagawa H
    J Immunol; 1987 Jun; 138(12):4150-8. PubMed ID: 3495581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.